Literature DB >> 26046079

Apyrase as a novel therapeutic inhibitor of heterotopic ossification.

Olin D Liang1, Anthony M Reginato1, Damian Medici1.   

Abstract

Year:  2015        PMID: 26046079      PMCID: PMC4437924          DOI: 10.3978/j.issn.2305-5839.2015.03.45

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  22 in total

1.  Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva.

Authors:  F H Gannon; F S Kaplan; E Olmsted; G C Finkel; M A Zasloff; E Shore
Journal:  Hum Pathol       Date:  1997-03       Impact factor: 3.466

2.  Sensory nerve induced inflammation contributes to heterotopic ossification.

Authors:  Elizabeth Salisbury; Eric Rodenberg; Corinne Sonnet; John Hipp; Francis H Gannon; Tegy J Vadakkan; Mary E Dickinson; Elizabeth A Olmsted-Davis; Alan R Davis
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

3.  Treatment of heterotopic ossification through remote ATP hydrolysis.

Authors:  Jonathan R Peterson; Sara De La Rosa; Oluwatobi Eboda; Katherine E Cilwa; Shailesh Agarwal; Steven R Buchman; Paul S Cederna; Chuanwu Xi; Michael D Morris; David N Herndon; Wenzhong Xiao; Ronald G Tompkins; Paul H Krebsbach; Stewart C Wang; Benjamin Levi
Journal:  Sci Transl Med       Date:  2014-09-24       Impact factor: 17.956

4.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

5.  Substance P signaling mediates BMP-dependent heterotopic ossification.

Authors:  Lixin Kan; Vitali Y Lounev; Robert J Pignolo; Lishu Duan; Yijie Liu; Stuart R Stock; Tammy L McGuire; Bao Lu; Norma P Gerard; Eileen M Shore; Frederick S Kaplan; John A Kessler
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

Review 6.  Inherited human diseases of heterotopic bone formation.

Authors:  Eileen M Shore; Frederick S Kaplan
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

7.  Functional modeling of the ACVR1 (R206H) mutation in FOP.

Authors:  Jay C Groppe; Eileen M Shore; Frederick S Kaplan
Journal:  Clin Orthop Relat Res       Date:  2007-09       Impact factor: 4.176

8.  BMP type I receptor inhibition reduces heterotopic [corrected] ossification.

Authors:  Paul B Yu; Donna Y Deng; Carol S Lai; Charles C Hong; Gregory D Cuny; Mary L Bouxsein; Deborah W Hong; Patrick M McManus; Takenobu Katagiri; Chetana Sachidanandan; Nobuhiro Kamiya; Tomokazu Fukuda; Yuji Mishina; Randall T Peterson; Kenneth D Bloch
Journal:  Nat Med       Date:  2008-11-30       Impact factor: 53.440

9.  Prophylaxis of heterotopic ossification - an updated review.

Authors:  Evan O Baird; Qian K Kang
Journal:  J Orthop Surg Res       Date:  2009-04-20       Impact factor: 2.359

Review 10.  Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis.

Authors:  Frederick S Kaplan; Salin A Chakkalakal; Eileen M Shore
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

View more
  1 in total

1.  Picking a bone with heterotopic ossification: translational progress current and future.

Authors:  Jonathan R Peterson; Shailesh Agarwal; Shawn J Loder; Oluwatobi Eboda; Paul S Cederna; Steven R Buchman; Chuanwu Xi; Stewart C Wang; Benjamin Levi
Journal:  Ann Transl Med       Date:  2015-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.